Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

18 nov. 2025 10h12 HE | Source: Research and Markets

Hemophilia A Research Report 2025-2035: Market Driven by Innovation from Alnylam, Pfizer, Roche, Novo Nordisk, and Takeda as Next-Generation Therapies and Emerging Market Expansion Bolsters Growth

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia A Market - A Global and Regional Analysis: Focus on Treatment Type, Country, and Region - Analysis and Forecast, 2025-2035" report has been...
18 nov. 2025 10h10 HE | Source: Research and Markets

Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia B Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
06 août 2024 10h00 HE | Source: Research and Markets

Hemophilia B Therapeutics Pipeline Research 2024: Comprehensive Insights About 15+ Companies and 20+ Drugs

Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Hemophilia B - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
04 mars 2024 11h21 HE | Source: Research and Markets

Hemophilia A Drug Pipeline Landscape Report 2024

Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Hemophilia A - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Explore Hemophilia A Treatment Landscape and...